Researchers at the Public Health Agency of Canada’s National Microbiology Laboratory (NML) have developed a new and easy-to-manufacture treatment for Ebola infection. Up to 90% of infections result in death within days of exposure. Given that no approved Ebola vaccine prevents infection, there is an urgent need for a treatment to improve survival rates after exposure. This new treatment can be effective when administered up to 48 hours after infection. “Our researchers have seenfirsthandtheterribleeffectsoftheEbolavirusonpopulationsinAfrica,”said Dr. Frank Plummer, Chief Science Officer at the Public Health Agency of Canada. “This discovery should pave the way for the development of a new drug that has the potential to save many lives.”
